Skip to main content

Advertisement

Log in

Effects of IS-741, a Synthetic Anti-Inflammatory Agent, on Bleomycin-Induced Lung Injury in Mice

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Bleomycin (BLM)-induced lung injury consists of excessive inflammatory cell infiltration and fibrosis. IS-741 has been reported to be an anti-inflammatory drug through an inhibitory action on cell adhesion. In this study we investigated whether IS-741 could inhibit the progression of pulmonary fibrosis through inflammatory cell infiltration. Lung injury was induced in female C57BL/6 mice by intratracheal instillation of BLM. IS-741 was administered daily intraperitoneally. The hydroxyproline content and fluid content in the lung on Day 28 were significantly lower in the IS-741-treated mice. The histological degree of lung injury or fibrosis was reduced in IS-741-treated mice. Administration of IS-741 caused significant reduction in the absolute number of total cells, monocyte chemoattractant protein (MCP)-1, and cysteinyl leukotriene (cysLTs) levels in bronchoalveolar lavage fluid on Day 7. Furthermore, the hydroxyproline content was significantly lower in IS-741-treated mice even though IS-741 was started on Day 14 after BLM instillation. Treatment with IS-741 had an inhibitory effect on BLM-induced lung injury and fibrosis via the repression of MCP-1 or cysLTs in this murine experimental model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Kuwahara F, Kai H, Tokuda K, Niiyama H, Tahara N, Kusaba K, Takemiya K, Jalalidin A, Koga M, Nagata T, Shibata R, Imaizumi T (2003) Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling. Hypertension 41:819–823

    Article  PubMed  CAS  Google Scholar 

  2. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH (2005) Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 16:1711–1722

    Article  PubMed  CAS  Google Scholar 

  3. Blaber R, Stylianou E, Clayton A, Steadman R (2003) Selective regulation of ICAM-1 and RANTES gene expression after ICAM-1 ligation on human renal fibroblasts. J Am Soc Nephrol 14:116–127

    Article  PubMed  CAS  Google Scholar 

  4. Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H (2005) Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 128:138–146

    Article  PubMed  CAS  Google Scholar 

  5. Huo Y, Ley K (2001) Adhesion molecules and atherogenesis. Acta Physiol Scand 173:35–43

    Article  PubMed  CAS  Google Scholar 

  6. American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646–664

    Google Scholar 

  7. Kimura H, Yotsuya S, Yuki S, Sugi H, Shigehara I, Haga T (1995) Synthesis and antipancreatitis activities of novel N-(2-sulfonylamino-5-trifluoromethyl-3-pyridyl) carboxamide derivatives as phospholipase A2 inhibitors. Chem Pharm Bull (Tokyo) 43:1696–1700

    CAS  Google Scholar 

  8. Isaji S, Hayashi J, Higashiguchi T, Yokoi H, Ogura Y, Noguchi T, Kawarada Y (1999) Effect of IS-741 (a new synthetic antiinflammatory agent) on acute necrotizing pancreatitis in dogs. Significance of its inhibitory effect on cytosolic phospholipase A2. Digestion 60(Suppl 1):47–51

    Article  PubMed  CAS  Google Scholar 

  9. Makino J, Andoh A, Hata K, Yotsuya S, Shikama H, Araki Y, Fujiyama Y, Bamba T (2002) Suppressive effects of a new anti-inflammatory agent, IS-741, on dextran sulfate sodium-induced experimental colitis in rats. Int J Mol Med 9:391–396

    PubMed  CAS  Google Scholar 

  10. Yamauchi J, Sunamura M, Shibuya K, Takeda K, Kobari M, Matsuno S (1999) A novel diamino-pyridine derivative prevents excessive leukocyte infiltration in aggravation of acute necrotizing pancreatitis. Digestion 60(Suppl 1):40–46

    Article  PubMed  CAS  Google Scholar 

  11. Yamaguchi Y, Okabe K, Liang J, Matsumura F, Akizuki E, Matsuda T, Ohshiro H, Nakano S, Ishihara K, Ogawa M (1999) The novel carboxamide derivative IS-741 reduces neutrophil chemoattractant production by bronchoalveolar macrophages in rats with cerulein-induced pancreatitis complicated by sepsis. Digestion 60(Suppl 1):52–56

    Article  PubMed  CAS  Google Scholar 

  12. Imamura T, Niikawa J, Kitamura K, Takahashi A, Ikegami A, Yoshida H, Tanaka S, Mitamura K (2003) Effect of IS-741 on ethionine-induced acute pancreatitis in rats: relation to pancreatic acinar cell regeneration. J Gastroenterol 38:260–267

    Article  PubMed  CAS  Google Scholar 

  13. Fukunaga T, Tsujikawa T, Sasaki M, Fujiyama Y, Bamba T, Fujimiya M (2003) A novel diamino-pyridine derivative (IS-741) attenuates rat ileitis induced by trinitrobenzene sulfonic acid. J Gastroenterol 38:451–459

    Article  PubMed  CAS  Google Scholar 

  14. Makino J, Andoh A, Hata K, Yotsuya S, Shikama H, Imamura M, Fujiyama Y, Bamba T (2002) Inhibitory effects of the new anti-inflammatory agent, IS-741, on spontaneous colitis in HLA-B27/beta2-microglobulin transgenic rats. J Gastroenterol Hepatol 17:854–860

    Article  PubMed  CAS  Google Scholar 

  15. Kaku T, Oono T, Zhao H, Gibo J, Kawabe K, Ito T, Takayanagi R (2007) IS-741 attenuates local migration of monocytes and subsequent pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Pancreas 34:299–309

    Article  PubMed  CAS  Google Scholar 

  16. Aono Y, Nishioka Y, Inayama M, Ugai M, Kishi J, Uehara H, Izumi K, Sone S (2005) Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 171:1279–1285

    Article  PubMed  Google Scholar 

  17. Azuma M, Nishioka Y, Aono Y, Inayama M, Makino H, Kishi J, Shono M, Kinoshita K, Uehara H, Ogushi F, Izumi K, Sone S (2007) Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice. Am J Respir Crit Care Med 176:1243–1250

    Article  PubMed  CAS  Google Scholar 

  18. Selman M, King TE, Pardo A (2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134:136–151

    PubMed  CAS  Google Scholar 

  19. Chaudhary NI, Schnapp A, Park JE (2006) Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med 173:769–776

    Article  PubMed  CAS  Google Scholar 

  20. Xie MJ, Motoo Y, Su SB, Iovanna JL, Sawabu N (2002) Effect of carboxamide derivative IS-741 on rat spontaneous chronic pancreatitis. Dig Dis Sci 47:139–147

    Article  PubMed  CAS  Google Scholar 

  21. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, Graves DT (1992) Expression of monocyte chemoattractant protein-1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 89:5371–5375

    Article  PubMed  CAS  Google Scholar 

  22. Iyonaga K, Takeya M, Saita N, Sakamoto O, Yoshimura T, Ando M, Takahashi K (1994) Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum Pathol 25:455–463

    Article  PubMed  CAS  Google Scholar 

  23. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, Walz A (1994) Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 149:655–659

    PubMed  CAS  Google Scholar 

  24. Suga M, Iyonaga K, Ichiyasu H, Saita N, Yamasaki H, Ando M (1999) Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 14:376–382

    Article  PubMed  CAS  Google Scholar 

  25. Zhang K, Gharaee-Kermani M, Jones ML, Warren JS, Phan SH (1994) Lung monocyte chemoattractant protein-1 gene expression in bleomycin induced pulmonary fibrosis. J Immunol 153:4733–4741

    PubMed  CAS  Google Scholar 

  26. Inoshima I, Kuwano K, Hamada N, Hagimoto N, Yoshimi M, Maeyama T, Takeshita A, Kitamoto S, Egashira K, Hara N (2004) Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 286:L1038–L1044

    Article  PubMed  CAS  Google Scholar 

  27. Peters-Golden M, Bailie M, Marshall T, Wilke C, Phan SH, Toews GB, Moore BB (2002) Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med 165:229–235

    PubMed  Google Scholar 

  28. Nagase T, Uozumi N, Ishii S, Kita Y, Yamamoto H, Ohga E, Ouchi Y, Shimizu T (2002) A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis. Nat Med 8:480–484

    Article  PubMed  CAS  Google Scholar 

  29. Salmi M, Jalkanen S (2005) Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 5:760–771

    Article  PubMed  CAS  Google Scholar 

  30. Hamaguchi Y, Nishizawa Y, Yasui M, Hasegawa M, Kaburagi Y, Komura K, Nagaoka T, Saito E, Shimada Y, Takehara K, Kadono T, Steeber DA, Tedder TF, Sato S (2002) Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis. Am J Pathol 161:1607–1618

    PubMed  CAS  Google Scholar 

  31. Shikama H, Yotsuya S, Satake S, Sugi H, Kato M (1999) Effect of IS-741 on cell adhesion between human umbilical vein endothelial cells and HL-60 cells. Biol Pharm Bull 22:127–131

    PubMed  CAS  Google Scholar 

  32. Yotsuya S, Shikama H, Imamura M (2001) Efficacy of the inflammatory cell infiltration inhibitor IS-741 on colitis induced by dextran sulfate sodium in the rat. Jpn J Pharmacol 87:151–157

    Article  PubMed  CAS  Google Scholar 

  33. Yotsuya S, Shikama H, Nakano I, Sakai K, Kato M, Sugi H, Takada H, Koga Y (1999) A novel synthetic anti-acute pancreatitis agent, IS-741. Digestion 60(Suppl 1):34–39

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the Health and Labour Sciences Research Grants on Diffuse Lung Diseases from the Japanese Ministry of Health, Labour and Welfare, Grant for Promotion of Niigata University Research Projects (90), and Research Grant from Shimane University Medical School Alumni Association.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shunji Tajima.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimaoka, Y., Tajima, S., Fujimori, F. et al. Effects of IS-741, a Synthetic Anti-Inflammatory Agent, on Bleomycin-Induced Lung Injury in Mice. Lung 187, 331–339 (2009). https://doi.org/10.1007/s00408-009-9162-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-009-9162-6

Keywords

Navigation